68Ga-PSMA-11 Clinical Trials
7 recruitingDrug
Phase 24Phase 33Phase 12Not Applicable1
Showing 1–7 of 7 trials
Recruiting
Phase 1Phase 2
Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer
Prostate Cancer
Weill Medical College of Cornell University52 enrolled4 locationsNCT04946370
Recruiting
Phase 2
Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal Function
Novartis Pharmaceuticals20 enrolled9 locationsNCT06004661
Recruiting
Phase 2Phase 3
68Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI
Prostate Cancer (Adenocarcinoma)
First Affiliated Hospital of Fujian Medical University100 enrolled1 locationNCT07209878
Recruiting
Not Applicable
68Ga-P16-093 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Primary Prostate Cancer Patients
Prostate Cancer
Peking Union Medical College Hospital50 enrolled1 locationNCT05324332
Recruiting
Phase 3
PSMA PET Combined With MRI for the Detection of PCa
Prostate CancerProstatic NeoplasmPCA+6 more
Telix Pharmaceuticals (Innovations) Pty Limited204 enrolled1 locationNCT07052214
Recruiting
Phase 1Phase 2
Prospective Clinical Trial of 225Ac-LNC1011 in the Treatment of Metastatic Castration-Resistant Prostate Cancer
Prostate Cancer
First Affiliated Hospital of Fujian Medical University20 enrolled1 locationNCT07117760
Recruiting
Phase 3
68Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese Patients
Prostate CancerBiochemical Recurrence of Malignant Neoplasm of ProstateBCR Prostate Carcinoma
Telix Pharmaceuticals (Innovations) Pty Limited110 enrolled8 locationsNCT05847348